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Abstract
This study aims to determine whether the prescription of a detailed lifestyle programme in overweight/obese preg-
nant women inﬂuences the occurrence of gestational diabetes (GDM), and if this kind of prescription increases the
adherence to a healthier lifestyle in comparison to standard care. The study was designed as a randomized con-
trolled trial, with open allocation, enrolling women at 9–12weeks of pregnancy with a BMI≥ 25kg/m2. The women
assigned to the Intervention group (I= 96) received a hypocaloric, low-glycaemic, low-saturated fat diet and physical
activity recommendations. Those assigned to the Standard Care group (SC=95) received lifestyle advices regarding
healthy nutrition and exercise. Follow-up was planned at the 16th, 20th, 28th and 36th weeks. A total of 131 women
completed the study (I = 69, SC=62). The diet adherence was higher in the I (57.9%) than in the SC (38.7%) group.
GDMoccurred less frequently in the I (18.8%) than in the SC (37.1%,P=0.019) group. The adherent women from
either groups showed a lower GDM rate (12.5% vs. 41.8%,P< 0.001). After correcting for confounders, the GDM
rate was explained by allocation into the I group (P=0.034) and a lower BMI category (P=0.039). The rates of
hypertension, preterm birth, induction of labour, large for gestational age babies and birthweight> 4000g were
signiﬁcantly lower in I group. The incidence of small for gestational age babies was not different.
These ﬁndings demonstrate that the adherence to a personalized, hypocaloric, low-glycaemic, low-saturated fat diet
started early in pregnancy prevents GDM occurrence, in women with BMI≥ 25kg/m2.
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Introduction
High pre-pregnancy body mass index (BMI) and exces-
sive gestational weight gain (GWG) are associated with
many unfavourable maternal and neonatal outcomes
(Cedergren 2006; Hedderson et al. 2006; Stotland et al.
2006; Leddy et al. 2008). Overweight/obese women
should be counselled regarding their body weight
before conception (ACOG 2005; NICE public health
guidance 27 2010); however, most women have access
to obstetricians only when they are pregnant. The Insti-
tute of Medicine (IOM) revised the guidelines of re-
commended GWG according to the BMI (Rasmussen
& Yaktine 2009); however, only a minority of women
succeed in reaching the target GWG (Carmichael et al.
1997; Abrams et al. 2000; Cedergren 2006). Among the
interventions aimed at preventing excessive GWG
(Muktabhant et al. 2015), few have demonstrated efﬁ-
cacy in high-risk populations (Wolff et al. 2008; Thornton
et al. 2009; Quinlivan et al. 2011); the principal issues are
population heterogeneity (Polley et al. 2002; Jeffries
et al. 2009; Luoto et al. 2011; Phelan et al. 2011), the inter-
ventional methods, (Wolff et al. 2008; Thornton et al.
2009; Quinlivan et al. 2011) and the timing of the inter-
ventional programmes (Polley et al. 2002; Tieu et al.
2008; Wolff et al. 2008; Jeffries et al. 2009; Thornton
et al. 2009; Callaway et al. 2010; Luoto et al. 2011; Phelan
et al. 2011; Quinlivan et al. 2011). Additionally, lifestyle
interventions did not have a substantial effect on other
clinical outcomes. Dietary advice to prevent gestational




diabetes mellitus (GDM) appears to be beneﬁcial in
general, although the results are overly heterogeneous
(Tieu et al. 2008). A systematic review concerning
exercise alone (Han et al. 2012) demonstrated no effect
on preventing GDM, whereas another study showed
only a slight protective effect (Russo et al. 2015).
Unfortunately, most of the reports evaluating the
efﬁcacy of diverse approaches (exercise, diet, lifestyle
interventions, dietary supplements) to prevent GDM
are of poor quality (Facchinetti et al. 2014).
Adherence to lifestyle recommendations could be a
major determinant of their efﬁcacy, speciﬁcally among
overweight/obese women. Previous studies investi-
gated adherence to speciﬁc dietary patterns (Englund-
Ogge et al. 2014; Gaskins et al. 2014; Hillesund et al.
2014) and their effect on pregnancy outcomes;
however, no study has investigated adherence among
overweight/obese pregnant women and its effect on
the onset of GDM.
This study aimed to determine whether the
prescription of a lifestyle programme, consisting of diet
and physical activity, in overweight and obese women
could affect the occurrence of GDM. It also aimed to
determine whether this kind of prescription inﬂuences
the adherence to healthier eating habits, and how this,
in turn, can inﬂuence the occurrence of GDM.
Research design and methods
Study design
This study was a prospective, randomized, open-label,
controlled trial that was approved by the local ethics
committee and registered at clinicaltrial.gov as
NCT01783210. All volunteers provided written in-
formed consent.
Pregnant women with a pre-pregnancy
BMI≥ 25kg/m2, an age >18years and a singleton
pregnancy were recruited by clinicians who were not
otherwise involved in the study from the public
antenatal clinics in Modena, Italy, and were enrolled
between their 9th and 12th weeks of pregnancy at the
Obstetric Unit of the Mother–Infant Department of
Azienda Ospedaliero-Universitaria, Policlinico di
Modena, from February 2013 to June 2014.
The exclusion criteria were chronic diseases, includ-
ing diabetes mellitus (ﬁrst trimester glycosuria
>100mg/dL or fasting plasma glucose ≥126mg/dL,
which are part of the routine tests prescribed in antena-
tal clinics and are performed in the ﬁrst trimester, or
random glycaemia≥ 200mg/dL), hypertension, medical
conditions or dietary supplements that might affect
body weight (i.e. thyroid diseases), previous bariatric
surgery, contraindications to exercise and intent to
deliver outside of our hospital. Additionally, previous
GDM and smoking habits (≥5 cigarettes per day),
which are both risk factors for GDM development
(Solomon et al. 1997), were considered exclusion
criteria to reduce the confounders possibly predispos-
ing participants to GDM or inﬂuencing GWG; the
results were thus concentrated only on the possible
effects of diet and exercise.
Eligible women who agreed to participate were
randomly assigned to the Intervention group (I) or
the standard care group (SC). The randomization list
was obtained by computer-generated random alloca-
tion with a 1:1 ratio. The allocations were sealed in
numbered white envelopes, which were kept in the
midwifery facility. After eligibility was assessed, a
midwife opened the next random envelope. Because
of the study design, the gynaecologist and the dietitian
knew the group allocation of the patient. The dietary
and physical interventions, prescribed according to
the group of allocation, are later described.
Eating habits were investigated through a food
frequency questionnaire (FFQ) at enrolment and again
Key messages
• In overweight/obese pregnant women the compliance to changes in lifestyle is poor (a quarter is lost to follow-up).
• A customized, prudent (low-glycemic, low saturate fat), hypocaloric diet started in the ﬁrst trimester halved the oc-
currence of GDM and the use of insulin.
• The higher is the adherence (switching to prudent diet), the lower is the occurrence of GDM, hypertensive disorders
and LGA babies. Personalizing diet through a dedicated dietitian increases the adherence, thus improving outcomes.
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at the 36th week of pregnancy. Subjects were told to
report their eating habits in the month preceding FFQ
administration.
Physical activity was investigated through a
pedometer (Odmron Walking Style III HJ-203-EK,
Omron Healthcare Co., Kyoto, Japan) that was
provided to women in both groups and had to be worn
for 1week three times during pregnancy (at enrolment
and at the 20th and 36th week). The pedometer was worn
by the participant on a belt at the back of the waist to
assess the number of steps and the duration of physical
activity.
The entire cohortwas administered a 75-g 2-h oral glu-
cose tolerance test (OGTT) during the 16th–18th weeks.
Testing was repeated in the 24th–28th weeks for women
whowere negative forGDM in the ﬁrst test. TheOGTTs
were performed in labs outside the hospital, and data
were collected at the next visit. GDM was diagnosed
according to the IADPSG criteria (i.e. fasting plasma
glucose≥ 92mg/dL and/or plasma glucose ≥ 180mg/dL
1h after administration and/or plasma glucose
≥ 153mg/dL 2h after the administration of glucose).
Dietary intervention
At enrolment, each woman attended a counselling
session lasting approximately 1h with a dietitian, who
either gave general recommendations ondiet andphysical
activity (SC) or prescribed a personalized dietary
intervention (I) with extensive explanation of meal
subdivision and possible food substitutions, according
to the group of allocation. Only one dietitian was
involved in the study; thus, she met with women from
both groups.
The women in the SC group received a simple nutri-
tional booklet regarding lifestyle, which was in accor-
dance with the Italian Guidelines for a healthy diet and
physical activity during pregnancy (ISS 2011; SINU
2012). The dietitian counselled the women on avoiding
foodwith a high glycaemic index, reducing the consump-
tion of foodwith a high saturated fat content and increas-
ing the consumption of vegetables and fruit with a low
glycaemic index.However, no speciﬁc indication on food
quantities, caloric intake, meal composition or meal
distribution was given. All the women in the SC group
received the same standard recommendations.
The women in the I group received speciﬁc,
personalized instructions and the dietary intervention
consisted of the prescription of a low-glycaemic, low-
saturated fat diet with a total intake of 1500kcal/day.
In light of the additional physical activity programme,
200kcal/day for obese and 300kcal/day for overweight
women were added (Mello & Buti 2010). The pre-
scribed diet was based on the wide consumption of
plant foods, cereals, legumes and ﬁsh, with olive oil as
the main source of fat, and moderate to no consump-
tion of red wine. The dietary plan provided three main
meals and three snacks (breakfast, snack, lunch, snack,
dinner and evening snack before bedtime); for each
meal or snack, the pregnant women had several
alternatives, all of which were suitably calibrated. The
diet had a target macronutrient composition of 55%
carbohydrates (80% complex carbohydrates with a
low glycaemic index and 20% simple carbohydrates),
20% protein (50% animal and 50% vegetable) and
25% fat (12%mono-unsaturated, 7% polyunsaturated
and 6% saturated) with moderately low saturated fat
levels. The daily recommended calories were divided
into small frequent meals to avoid ketonuria and
acidosis, which frequently occurs because of prolonged
fasting. The daily intake of carbohydrates was at
least 225g/day, which is sufﬁcient to prevent ketosis
(Bier et al. 1999). The primary focus of the dietary
intervention was decreasing the consumption of
foods with a high glycaemic index and a high saturated
fat content by substituting them with healthier
alternatives based on the taste and preferences of the
women.
Physical intervention
The physical intervention was focused on developing a
more active lifestyle. The physical activity prescription
was consistent with recommendations by the ACOG
(ACOG 2002) and the ACSM (Pivarnik et al. 2006)
for pregnant women. The subjects were advised to
participate in 30min of moderate intensity activity at
least three times a week. The ‘talk test’ (being able to
maintain a conversation during activity) was suggested
to monitor the exercise intensity. Independent of the
group of allocation, all women received the prescrip-
tion of physical activity.
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Follow-up examinations
The follow-up examinations were scheduled for the
16th, 20th, 28th and 36th weeks of pregnancy with both
the gynaecologist and the dietitian. The participant’s
weight was measured at each follow-up visit. In
addition, women in the I group were interviewed by
the dietitian about their eating and physical habits at
each follow-up examination and then counselled about
possible dietary changes when necessary, whereas
women in group SC were simply asked about their
adherence to the suggested lifestyle.
Data collection
At enrolment, the obstetric, family and personal
histories of the participants were collected by a
gynaecologist and the dietitian; in particular, parity
and family history of diabetes and hypertension were
recorded. The weight (using the BIA Tanita, Tokyo,
Japan) and height (using a stadiometer) of the subjects
were measured. Weight measurements were always
performed on unclothed subjects. The pre-pregnancy
BMI was calculated as the self-reported pre-pregnancy
weight (kg)/height (m)2.
At enrolment, each subject completed the FFQ to
investigate her eating habits in the previous month.
The FFQ was then completed again at the 36th week
of pregnancy, investigating their eating habits in the pre-
vious month, to evaluate their compliance with the
prescribed/suggested nutritional changes. The women
who did not attend the 36th week examination received
a phone call from the clinicians to conduct the interview.
The participant’s weightwasmeasured at each follow-
up examination as reported above. After the last exam-
ination, women were told to measure their weight every
2–3days. The last weight measurement before delivery
was self-reported by each subject either during their stay
at the hospital after delivery or by phone. For all partic-
ipating women, whether their weight gain at each
follow-up visit and at delivery was below the suggested
upper limits of weight gain was recorded. The limits
for weight gain were deﬁned by the IOM (3kg in the
ﬁrst trimester plus 0.33kg/week in the second and third
trimester for overweight women; 2kg in the ﬁrst trimes-
ter plus 0.27kg/week in the second and third trimester
for obese women) (Rasmussen & Yaktine 2009).
The ketonuria rate was assessed with routine urine
exams at enrolment and over the 18th–20th weeks,
24th–27th weeks and 33rd–36th weeks.
The obstetrician in charge of the enrolled women
was blind to the allocation group. The data regarding
the delivery and the newborns were collected from
the clinical records by two residents who were blind to
the allocation group. In particular, the mode of and
gestational age at delivery, birth weight, Apgar score
at the 5th minute, and need for resuscitation and
admission to a neonatal intensive care unit (NICU)
were recorded.
The birth weight centile was calculated in relation
to the gestational age according to a large Italian
study on neonatal anthropometrics (Bertino et al.
2010). Large for gestational age (LGA) was deﬁned
as a birth weight≥ the 90th centile; small for
gestational age (SGA) was deﬁned as a birth weight
≤ the 10th centile.
The protocol that was originally published in
ClinicalTrials.gov has since beenmodiﬁed.We changed
the primary outcome from GWG after acknowledging
that GWG is only a proxy outcome and is inﬂuenced
by a number of factors that may be independent from
diet and physical activity. In fact, GWG can be the
result of different changes in body composition, in
terms of fat mass, fat-free mass and water, which could
vary widely from one subject to another and be
unrelated to pregnancy outcomes. We then decided to
focus on a common pregnancy complication and shifted
the primary outcome to GDM, which has a signiﬁcant
impact on pregnancy management and outcomes and,
from an epidemiological point of view, includes
overweight and obesity as major risk factors. The
primary outcome was therefore changed (GDM rate
replaced GWG occurrence) as well as secondary
outcomes (GDM was removed and additional
outcomes included as reported below). These changes
were made before the preliminary analyses.
The primary outcome was the occurrence of GDM.
The secondary outcomes were GWG, adoption of
healthy nutrition practices (evaluated through FFQ),
rate of pregnancy-induced hypertension (PIH) and
preterm birth (PTB), mode of delivery, birth weight
and its distribution, Apgar score at 5min, need for
resuscitation and rate of (NICU) admission.
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FFQ and the diet adherence score
The proposed FFQ was a questionnaire that investi-
gated both frequency and quantity of the consumption
of approximately 40 types of food, primarily to evaluate
the intake of saturated fat, carbohydrates with a high-
glycaemic index and ﬁbre. The development, reproduc-
ibility and validity of the test have been described in
previous studies (Boeing et al. 1997; Bohlscheid-
Thomas et al. 1997; da Vico et al. 2012). In the analysis
of eating patterns, we considered the consumption of
the following to be positive habits: (1) at least two serv-
ings per day of raw or cooked vegetables; (2) a maxi-
mum of 30 g of sugar per day (including simple sugars,
sweetened beverages and sweet foods); and (3) foods
rich in saturated fats (including butter, margarine,
cheese and sauces) at a maximum of 3 times a week.
A score (ranging from 0 to 3) was calculated, assigning
one point to each category of the class of
foods/nutrients described above. If a woman remained
within the suggested range of consumption, she scored
a 1; otherwise, she scored a 0. This score was intended
to be an index of adequate nutrition and was
considered to be an indicator of the adherence to the
prescribed diet. The subjects who scored at least two
out of three were considered to have properly adhered
to a healthy diet, independent of the group of
allocation.
Statistical analysis
According to previous observations, we expected a
GDM occurrence of approximately 40% in
overweight/obese women. The power of the study was
calculated with the hypothesis that the intervention
was able to reduce the occurrence of GDM by 50%.
Thus, 60 women per arm would be sufﬁcient to observe
a statistically signiﬁcant difference.
To compare the continuous variables, the Student’s
t-test was employed. A Chi-squared test was used for
the categorical variables. For the demographic
variables, we used the frequencies and Student’s t-test
comparisons. A logistic regression was used to evaluate
the determinants for GDM occurrence and diet
adherence with respect to the confounding variables.
The data are reported as the mean±SD or numbers
with % in brackets. We considered a P-value less than
0.05 as the threshold for statistical signiﬁcance. The
data were analysed with SPSS Statistics software
v 21.0 (SPSS Statistics software v 21.0, IBM Corp.,
Armonk, NY, USA).
Results
Two hundred and thirty-eight women would have been
eligible during the period of the study. Of them, 47
refused to participate; therefore, we randomized 191
women. Ninety-six subjects were allocated to the I
group and 95 to the SC group. The sociodemographic
characteristics at the time of randomization are
summarized in Table 1.
The BMI categories, including morbidly obese
women (I group: 10; SC Group: 8), were equally
distributed. The occurrence of miscarriages was 7.3%
in the I group and 6.3% in the SC group. Overall, 47
women were lost to follow-up, leaving 69 women in
the I group and 62 in the SC group to be analysed.
The ﬂow chart of the study is reported in Fig. 1.
The women who were lost to follow-up, when
compared with the women who remained in the study,
were younger (30.1± 5.9 vs. 31.7± 4.9 years, respec-
tively, P=0.04), had a lower education (50% vs.
33.6%, P=0.037) and were more frequently over-
weight (41.7% vs. 26%, P=0.029). Ethnicity and parity
did not seem to differ between the dropouts and the
women who completed the study.
In the I group, only two women (2.9%) missed one
follow-up visit, whereas in the SC group, nine women
(14.5%) missed one follow-up visit, and four women
(6.5%) missed two follow-up visits (P=0.003), includ-
ing two cases who delivered before 36th week.
The maternal weight at enrolment and GWG
measured at follow-up are reported in Table 2. No
difference between the groups was observed, even after
stratifying by pre-pregnancy BMI categories. Similarly,
the rate of women remaining within the IOM
recommendations was not different in the two groups
(at 12th week: 56.5% in I group vs. 43.3% in SC group;
at 16th week: 53.6% vs. 53.2%; at 20th week: 44.9% vs.
46.6%; at 28th week: 48.5% vs. 48.3%; at 36th week:
51.5% vs. 49%; and self-reported at delivery: 71% vs.
78.7%, respectively).
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At enrolment, the FFQ showed that only 12 women
in the SC group (19.4%) and 12 women in the I group
(17.4%) had adequate nutritional intake in the
previous month (FFQ score≥ 2). Of the women who
had a low FFQ score (≤1) at enrolment (50 in the SC
group, 57 in the I group), 14 (28%) in the SC group
and 28 (49.1%) in the I group improved to a FFQ
score≥ 2 at the 36th week (P=0.026). Thus, the
percentages of the women with adequate consumption
of vegetables, sugar and saturated fat at 36th week
was signiﬁcantly higher in group I than in group SC
(Table 3). Two women in group I and 2 women in
the SC group showed mild ketonuria (detectable but
<30mg/dL).
Table 1. Socio-demographic characteristics
Group I (96) Group SC (95)
Age (y) 31.5 ± 5 30.8 ± 5.5
Ethnicity Caucasian 79 (82.3%) Caucasian 78 (82.1%)
African 12 (12.6%) African 13 (13.7%)
Others 5 (5.2%) Others 4 (4.3%)
Education Low middle school: 39 (40.6%) Low middle school: 35 (35.9%)
Job Housewife: 26 (27%) Housewife: 37 (38.9%)
Handiwork: 23 (24%) Handiwork: 20 (21.1%)
Sedentary work: 47 (49%) Sedentary work: 38 (40%)
Nulliparity 53 (55.2%) 59 (62.1%)
Gestational age at enrollment (d) 74.8 ± 7.7 75.6 ± 9.1
Family history of diabetes 55 (57.3%) 50 (52.6%)
Pre-pregnancy BMI (kg/m
2
) 33.3 ± 6 33.4 ± 5.5
Obese 63 (65.6%) 69 (72.6%)
Fig. 1. Flow chart of the study.
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The number of steps (SN)/day and the duration of
physical activity in minutes (DPA) were not different
between the two groups neither at enrolment (SN
7788±3870 in I group vs. 8335± 3320 in SC group;
DPA 52.1± 35.9 vs. 50.4 ± 30.1, respectively) nor at the
20th week (SN 7505±3554 vs. 7998± 2972, respectively;
DPA 44.2± 28.8 vs. 53.9± 34.8, respectively). However,
at 36th week, women in the group I were less active than
those in the group SC (SN 6144±2889 vs. 7749± 3343,
P=0.016; DPA 34.1± 25.0 vs. 45.1 ± 35.1, P=0.039).
The SN andDPAwere not different between the obese
and the overweight women at the enrolment and
follow-up, independently of the allocation group.
Overall, the occurrence of GDM was lower in the I
group than in the SC group (18.8% vs. 37.1%, respec-
tively, P=0.019). GDM diagnosed at the 16th–18th
weeks of pregnancy was lower in group I than SC,
although this difference did not reach statistical
signiﬁcance (11.6% vs. 24.2%, respectively, P=0.058).
Insulin treatment was required in 6/13 cases in the I
group and in 12/23 cases in group SC.
Considering the whole population in the study and
merging the two groups, GDM occurred more
frequently in obese (33%) than in overweight women
(11.8%; P=0.017), whereas the GWG at delivery was
signiﬁcantly lower in obese (8.9 ± 7.2kg) than in
overweight women (12.4± 6.1 kg; P=0.011).
Interestingly, the FFQ score obtained by each
woman at the 36th week was inversely related to the
occurrence of GDM. Indeed, the GDM rate was
48.3% (14/29) in women with a FFQ score= 0 (poor
diet), 36.8% (14/38) in women with a FFQ score= 1,
13.3% (6/45) in women with a FFQ score= 3 and
10.5% (2/19) in women with a FFQ score= 4.
For the purpose of our study, however, we used FFQ
scores as a dichotomous variable and considered
‘healthy eaters’ those who scored a 2 or 3 and ‘bad
eaters’ those who scored a 0 or 1. As reported above,
adherence to a healthy diet (FFQ at week 36≥ 2) was
signiﬁcantly related to a lower occurrence of GDM
(12.5% in the adherent women and 41.8% in the non-
adherent ones, P < 0.001). This difference was particu-
larly evident in the sub-group of obese women (12.5%
among adherent women vs. 53.1% among non-
adherent women, P< 0.001). The different rates of
GDM between the adherent and non-adherent women
were still present when separately considering the I
group (10% vs. 31%, respectively; P=0.027) and the
SC group (16.7% vs. 50%, respectively; P=0.008).
In the logistic regression, GDM occurrence was
explained by the group of allocation (P=0.034) and
the pre-pregnancy BMI (P=0.039) after adjusting for
confounders (family history of diabetes, age≥ 35 years,
Caucasian ethnicity), while adherence to a healthy diet
was explained only by the group of allocation
(P=0.043), after adjusting for confounders (low
education, BMI≥ 30, age≥ 35 years, sedentary work,
Caucasian ethnicity).
The incidences of PIH, PTB (two spontaneous deliv-
eries and three inductions of labour because of uncon-
trolled PIH) and induction of labour were signiﬁcantly





Weight at enrollment (kg) 92.6 ± 16.4 94.6 ± 15 0.458
BMI at enrollment (kg/m2) 33.9 ± 5.7 34.5 ± 6.8 0.587
GWG at enrollment (kg) 1.6 ± 3.6 2.2 ± 3.7 0.392
GWG at 16
th
week (kg) 2.7 ± 4.1 2.7 ± 4.3 0.964
GWG at 20th week (kg) 4.8 ± 4.7 4.8 ± 5.3 0.993
GWG at 28
th
week (kg) 7.2 ± 5.7 6.8 ± 5.5 0.642
GWG at 36th week (kg) 9.5 ± 6.4 9.1 ± 6.7 0.749
Self-reported GWG at
delivery (kg)
10.1 ± 7.4 9.4 ± 6.8 0.557
Table 3. FFQ analysis at 36th week
Group I (69) Group SC (62) P-value
≥2 servings of vegetables/day 34 (49.3%) 26 (41.9%) 0.400
≤30 g of sugar/day 39 (56.5%) 23 (37.1%) 0.026
≤3 times/week of food rich in saturated fat 36 (52.2%) 27 (43.5%) 0.324
FFQ score† ≥ 2 40 (57.9%) 24 (38.7%) 0.028
†See Materials and methods for calculation details
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lower in group I. The incidence of LGA babies was
signiﬁcantly lower in group I, as was the number of
newborns with a birth weight >4000g, whereas the
incidence of SGA babies was similar between the two
groups (Table 4). An Apgar score≤ 7 at the 5th minute
was recorded in ﬁve cases in the SC group and four
cases in group I. Newborns requiring resuscitation (8)
as well as those admitted to the NICU (3) were very
few and did not differ between the groups. There were
two stillbirths in the SC group.
Discussion
Previous studies have found that speciﬁc lifestyle inter-
ventions could improve some pregnancy outcomes in
overweight and obese women. However, no study has
focused on the role of adherence to the prescribed
lifestyle changes as a strong determinant of their
efﬁcacy. In particular, no study has evaluated whether
adherence to healthy nutrition practices could inﬂuence
pregnancy outcomes in that population.
Our study aimed to determine whether a lifestyle
intervention, consisting of individualized counselling
by a dietitian with the prescription of a hypocaloric,
low-glycaemic, low-fat diet associated with physical
activity and a close follow-up, could have an effect on
GDM occurrence and how adherence, in terms of the
successful adoption of healthier eating habits, could
inﬂuence this outcome.
GDM occurrence was greatly reduced in the group
of women receiving the prescribed lifestyle interven-
tion with respect to those receiving generic
counselling only. Moreover, GDM prevention was
more evident in women who had a higher adherence
to the programme, as demonstrated by changes in
their nutritional intake. Adherence to healthy nutri-
tion can thus be considered a strong determinant of
the efﬁcacy of the intervention.
The FFQ score that we used to identify women’s
eating habits could be considered an effective tool for
collecting dietary intake. However, as FFQ is a
self-reported, semi-quantitative method investigating
the consumption of speciﬁc classes of food, its reliability
is still a topic of discussion (Erkkola et al. 2001; Barbieri
et al. 2015).
A recent meta-analysis of the literature (Bain et al.
2015) reported that combined diet and exercise inter-
ventions have no clear effects on the occurrence of
GDM, but no ﬁrm conclusions were drawn because of
the heterogeneity of the interventions and the included
populations. Of paramount importance, few, if any,
studies addressed the issue of compliance, and only half
of them recorded a healthier diet (lower consumption
of high fat and high glycaemic index food) or increased
physical activity.
Several secondary outcomes of pregnancy were eval-
uated in our study, including the rates of PIH, PTB and
LGA infants, which were reduced in the intervention
group, whereas the rate of SGA infants remained unaf-
fected. These results are consistent with those of a
recent meta-analysis (Thangaratinam et al. 2012). The
reduction in the rate of LGA babies, with an identical
rate of SGA, demonstrates that a hypocaloric yet nutri-
tionally balanced diet in overweight or obese women
Table 4. Maternal and neonatal outcomes
Group I (69) Group SC (62) P-value
GDM diagnosis 13 (18.8%) 23 (37.1%) 0.019
Pregnancy-induced hypertension 2 (2.9%) 13 (21%) 0.001
Preterm birth 0 5 (8.1%) 0.016
Gestational age at delivery (days) 277.3 ± 8.3 275 ± 10.6 0.142
Induction of labour 24 (34.8%) 34 (54.8%) 0.021
Caesarean delivery 17 (24.6%) 25 (40.3%) 0.055
Birth-weight (g) 3432.5 ± 333.7 3512.3 ± 447.3 0.246
LGA infants (≥90th centile) 1 (1.4%) 7 (11.3%) 0.019
Macrosomia (>4000 g) 2 (2.9%) 7 (11.3%) 0.058
SGA infants (≤10th centile) 6 (8.7%) 5 (8.1%) 0.897
GDM, gestational diabetes mellitus; LGA, large for gestational age; SGA, small for gestational age.
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does not cause fetal growth restriction, which could be a
major concern among physicians. Moreover, the
reduction in LGA babies could be beneﬁcial in reduc-
ing short- and long-term issues, including a major risk
of developing cardiovascular and metabolic diseases
in adult life (Catalano & Ehrenberg 2006).
Despite the observed improvement in maternal and
neonatal outcomes, GWG remained unaffected by the
behavioural intervention. This ﬁnding is in contrast
with other reports (Wolff et al. 2008; Thornton et al.
2009; Quinlivan et al. 2011) and even with our previous
pilot study (Petrella et al. 2014). Other authors (Polley
et al. 2002; Jeffries et al. 2009; Guelinckx et al. 2010;
Luoto et al. 2011) have demonstrated that various
interventions have no effect on limiting GWG.
The latest revision of a Cochrane review
(Muktabhant et al. 2015) found that diet or physical
activity or both are effective in preventing excessive
GWG in this population. In our study, for unknown
reasons, women allocated in the control group were
even more active than those in the intervention group,
and this could possibly have limited their GWG. It is
possible that women in the SC group, who had a higher
GDM occurrence, were more motivated to engage in
physical activity than women in the I group. However,
it is notable that in both groups, the number of
steps/day and the time spent on physical activity were
above the suggested values.
On the other hand, it has to be considered thatGWG
is just an approximate marker because an identical
increase in weight could lead to a diverse body
composition. Thus, it would be more meaningful, in
terms of metabolic impact, to evaluate the effect of an
intervention not solely on GWG but on the changes
in fat and fat-free mass. As a further limitation, GWG
at delivery was self-reported by women, and it shows
a possible informational bias. Throughout pregnancy
body weight was objectively measured by the investiga-
tors, and the rate of women not exceeding recom-
mended GWG remained stable around 40–50%,
while, unexpectedly, self-reported body weight before
delivery showed around 75% of women not exceeding
recommended GWG. Self-reported GWG cannot,
therefore, be considered a reliable measurement.
This study demonstrates that the current practice of
providing general lifestyle advice to overweight/obese
women through leaﬂets or directly by providers is not
sufﬁcient to reduce the occurrence of GDM and other
related complications such as LGA and macrosomia.
There could be several reasons for this, including the
following: poormotivation, which could cause the inter-
vention to be ineffective; inadequate communication;
or difﬁculties experienced by the women in
implementing general or excessively vague daily life
recommendations.
A structured, multidisciplinary approach, using a
programme that includes a personalized low-glycaemic
hypocaloric diet, physical activity motivation and
planned follow-up, could address these issues and
increase adherence to a healthier lifestyle.
To reach this goal, several efforts are required,
including the participation of a consultant dietitian
and dedicated staff to implement a close follow-up.
However, despite all of the resources available,
approximately a quarter of the women were lost to
follow-up, suggesting that a remarkably greater effort
is required to motivate and maintain the interest of
obese pregnant women.
In conclusion, a healthier lifestyle prescription for
overweight/obese women, consisting of a personalized,
hypocaloric, low-glycaemic diet with a low content of
saturated fat associated with moderately intense
physical activity, reduced the occurrence of GDM
through a signiﬁcant improvement in eating habits.
Acknowledgments
Wewould like to extend our appreciation to thewomen
who participated in the trial and the residents and
midwives who collaborated with the research group.
Source of Funding
The study was supported by fundings from Policlinico
University Hospital of Modena. The funders had no
role in the study design, data collection or analysis,
decision to publish or preparation of the article.
Conﬂict of Interest
The authors declare that they have no conﬂict of
interest.
Lifestyle, overweight and gestational diabetes 9
© 2016 John Wiley & Sons Ltd Maternal & Child Nutrition (2016), ••, pp. ••–••
Contributions
The contribution of each author is as follows: RB,
EP, GP, IN and FF are gynaecologists, who contributed
by planning the study, collecting data, performing the
statistical analyses and interpretation, writing and revis-
ing the manuscript and ﬁnal approval of the submitted
manuscript. RB and EP were involved in enrollment
and follow-up of the women. VB is the dietitian who
developed the low-glycaemic diet and was responsible
for counselling about nutrition and physical activity.
She helped interpreting data, and she revised and
approved the ﬁnal manuscript.
References
Abrams B., Altman S.L. & Pickett K.E. (2000) Pregnancy
weight gain: still controversial. American Journal of Clinical
Nutrition 71, 1233S–41S.
ACOG (2002) ACOG Committee opinion. Number 267,
January 2002: exercise during pregnancy and the postpar-
tum period. Obstetrics and Gynecology 99, 171–3.
ACOG (2005) ACOG Committee Opinion number 315,
September 2005. Obesity in pregnancy. Obstetrics and
Gynecology 106, 671–5.
Bain E., Crane M., Tieu J., Han S., Crowther C.A. &
Middleton P. (2015) Diet and exercise interventions for
preventing gestational diabetesmellitus.CochraneDatabase
of Systematic Reviews 4 CD010443. doi: 10.1002/14651858.
CD010443.pub2
Barbieri P., Crivellenti L.C., Nishimura R.Y. & Sartorelli D.S.
(2015) Validation of a food frequency questionnaire to
assess food group intake by pregnant women. Journal of
Human Nutrition and Dietetics 28 (Suppl 1), 38–44.
Bertino E., Spada E., Occhi L., Coscia A., Giuliani F.,
Gagliardi L. et al. (2010) Neonatal anthropometric charts:
the Italian neonatal study compared with other European
studies. Journal of Pediatric Gastroenterology and Nutrition
51, 353–61.
Bier D.M., Brosnan J.T., Flatt J.P., Hanson R.W., Heird W.,
Hellerstein M.K. et al. (1999) Report of the IDECG
Working Group on lower and upper limits of carbohydrate
and fat intake. European Journal of Clinical Nutrition 53,
s177–8.
Boeing H., Bohlscheid-Thomas S., Voss S., Schneeweiss S. &
Wahrendorf J. (1997) The relative validity of vitamin intakes
derived from a food frequency questionnaire compared to
24-hour recalls and biological measurements: results from
the EPIC pilot study in Germany. European Prospective
Investigation into Cancer and Nutrition. International
Journal of Epidemiology 26 (Suppl 1), S82–90.
Bohlscheid-Thomas S., Hoting I., Boeing H. & Wahrendorf J.
(1997) Reproducibility and relative validity of energy and
macronutrient intake of a food frequency questionnaire
developed for the German part of the EPIC project.
European Prospective Investigation into Cancer and Nutri-
tion. International Journal of Epidemiology 26 (Suppl 1),
S71–81.
Callaway L.K., Colditz P.B., Byrne N.M., Lingwood B.E.,
Rowlands I.J., Foxcroft K. et al. (2010) Prevention of
gestational diabetes: feasibility issues for an exercise
intervention in obese pregnant women. Diabetes Care 33,
1457–9.
Carmichael S., Abrams B. & Selvin S. (1997) The pattern of
maternal weight gain in women with good pregnancy
outcomes. American Journal of Public Health 87, 1984–8.
Catalano P.M. & Ehrenberg H.M. (2006) The short-and long-
term implications of maternal obesity on the mother and
her offspring. BJOG 113 (10), 1126–1133.
Cedergren M. (2006) Effects of gestational weight gain and
body mass index on obstetric outcome in Sweden. Interna-
tional Journal of Gynaecology and Obstetrics 93, 269–74.
Da Vico L., Agostini S., Brazzo S., Bifﬁ B. & Masini M.L.
(2012)Mediterranean diet: not only food.Monaldi Archives
for Chest Disease 78, 148–54.
Englund-Ogge L., Brantsaeter A.L., Sengpiel V., Haugen M.,
Birgisdottir B.E., Myhre R. et al. (2014) Maternal dietary
patterns and preterm delivery: results from large prospec-
tive cohort study. BMJ 348, g1446.
Erkkola M., Karppinen M., Javanainen J., Rasanen L.,
KnipM.&Virtanen S.M. (2001)Validity and reproducibility
of a food frequency questionnaire for pregnant Finnish
women. American Journal of Epidemiology 154, 466–76.
Facchinetti F., Dante G., Petrella E. & Neri I. (2014) Dietary
interventions, lifestyle changes, and dietary supplements in
preventing gestational diabetes mellitus: a literature review.
Obstetrical and Gynecological Survey 69, 669–80.
Gaskins A.J., Rich-Edwards J.W., Hauser R., Williams P.L.,
GillmanM.W., PenziasA. et al. (2014) Prepregnancy dietary
patterns and risk of pregnancy loss. American Journal of
Clinical Nutrition 100, 1166–72.
Guelinckx I., Devlieger R., Mullie P. & Vansant G. (2010)
Effect of lifestyle intervention on dietary habits, physical
activity, and gestational weight gain in obese pregnant
women: a randomized controlled trial. American Journal
of Clinical Nutrition 91, 373–80.
Han S., Middleton P. & Crowther C.A. (2012) Exercise for
pregnant women for preventing gestational diabetes mellitus.
Cochrane Database of Systematic Reviews 7 CD009021. doi:
10.1002/14651858.CD009021.pub2
Hedderson M.M., Weiss N.S., Sacks D.A., Pettitt D.J.,
Selby J.V., Quesenberry C.P. et al. (2006) Pregnancy
weight gain and risk of neonatal complications:
macrosomia, hypoglycemia, and hyperbilirubinemia.
Obstetrics and Gynecology 108, 1153–61.
10 R. Bruno et al.
© 2016 John Wiley & Sons Ltd Maternal & Child Nutrition (2016), ••, pp. ••–••
Hillesund E.R., Overby N.C., Engel S.M., Klungsoyr K.,
Harmon Q.E., Haugen M. et al. (2014) Associations of ad-
herence to the New Nordic Diet with risk of preeclampsia
and preterm delivery in the Norwegian Mother and Child
Cohort Study (MoBa). European Journal of Epidemiology
29, 753–65.
ISS (2011) Istituto Superiore di Sanità: Linee Guida per la
gravidanza ﬁsiologica [Online]. Available: http://www.snlg-
iss.it/cms/ﬁles/LG_Gravidanza.pdf.
Jeffries K., Shub A., Walker S.P., Hiscock R. & Permezel M.
(2009) Reducing excessive weight gain in pregnancy: a
randomised controlled trial. Medical Journal of Australia
191, 429–33.
Leddy M.A., Power M.L. & Schulkin J. (2008) The impact of
maternal obesity on maternal and fetal health. Review of
Obstetrics & Gynecology 1, 170–8.
Luoto R., Kinnunen T.I., Aittasalo M., Kolu P., Raitanen J.,
Ojala K. et al. (2011) Primary prevention of gestational
diabetes mellitus and large-for-gestational-age newborns
by lifestyle counseling: a cluster-randomized controlled trial.
PLoS Medicine 8 e1001036. doi: 10.1371/journal.
pmed.1001036. Epub 2011 May 17
Mello G. & Buti G. (2010) Nutrizione e gravidanza. In:
Nutrizione Individuo Popolazione (ed SEU, Rome;
P. Binetti, M. Marcelli & R. Baisi).
Muktabhant B., Lawrie T.A., Lumbiganon P. &
Laopaiboon M. (2015) Diet or exercise, or both, for
preventing excessive weight gain in pregnancy. Cochrane
Database of Systematic Reviews 6 CD007145.
NICE public health guidance 27 (2010). Weight management
before, during and after pregnancy.
Petrella E., Malavolti M., Bertarini V., Pignatti L., Neri I.,
Battistini N.C. et al. (2014) Gestational weight gain in
overweight and obese women enrolled in a healthy lifestyle
and eating habits program. Journal of Maternal-Fetal and
Neonatal Medicine 27, 1348–52.
Phelan S., Phipps M.G., Abrams B., Darroch F., Schaffner A.
& Wing R.R. (2011) Randomized trial of a behavioral
intervention to prevent excessive gestational weight gain:
the Fit for Delivery Study. American Journal of Clinical
Nutrition 93, 772–9.
Pivarnik J.M., Chambliss H.O., Clapp J.F., Dugan S.A.,
Hatch M.C., Lovelady C.A. et al. (2006) Impact of physi-
cal activity during pregnancy and postpartum on chronic
disease risk. Medicine and Science in Sports and Exercise
38, 989–1006.
Polley B.A., Wing R.R. & Sims C.J. (2002) Randomized
controlled trial to prevent excessive weight gain in pregnant
women. International Journal of Obesity and Related
Metabolic Disorders 26, 1494–502.
Quinlivan J.A., Lam L.T. & Fisher J. (2011) A randomised
trial of a four-step multidisciplinary approach to the
antenatal care of obese pregnant women. Australian and
New Zealand Journal of Obstetrics and Gynaecology 51,
141–6.
Rasmussen K.M. & Yaktine A.L. (2009) Institute of
Medicine (US) and National Research Council (US) Com-
mittee to Reexamine IOM Pregnancy Weight Guidelines.
In: Weight Gain During Pregnancy: Reexamining the
Guidelines (eds K.M. Rasmussen & A.L. Yaktine).
Washington (DC).
Russo L.M., Nobles C., Ertel K.A., Chasan-Taber L. &
Whitcomb B.W. (2015) Physical activity interventions in
pregnancy and risk of gestational diabetes mellitus: a
systematic review and meta-analysis. Obstetrics and
Gynecology 125, 576–82.
SINU (2012) Recommended Levels Intake of Energy and
Nutrients for the Italian Population, LARN (Livelli di
Assunzione Raccomandati di Energia e di Nutrienti per la
Popolazione Italiana).
Solomon C.G., Willett W.C., Carey V.J., Rich-Edwards J.,
Hunter D.J., Colditz G.A. et al. (1997) A prospective study
of pregravid determinants of gestational diabetes mellitus.
JAMA 278, 1078–1083.
Stotland N.E., Cheng Y.W., Hopkins L.M. & Caughey A.B.
(2006) Gestational weight gain and adverse neonatal
outcome among term infants. Obstetrics and Gynecology
108, 635–43.
Thangaratinam S., Rogozinska E., Jolly K., Glinkowski S.,
Roseboom T., Tomlinson J.W. et al. (2012) Effects of
interventions in pregnancy onmaternal weight and obstetric
outcomes: meta-analysis of randomised evidence. BMJ
344, e2088.
ThorntonY.S., SmarkolaC., Kopacz S.M.& Ishoof S.B. (2009)
Perinatal outcomes in nutritionally monitored obese
pregnant women: a randomized clinical trial. Journal of the
National Medical Association 101, 569–77.
Tieu J., Crowther C.A. & Middleton P. (2008) Dietary advice
in pregnancy for preventing gestational diabetes mellitus.
Cochrane Database of Systematic Reviews CD006674. doi:
10.1002/14651858.CD006674.pub2.
Wolff S., Legarth J., Vangsgaard K., Toubro S. & Astrup A.
(2008) A randomized trial of the effects of dietary counsel-
ing on gestational weight gain and glucose metabolism in
obese pregnant women. International Journal of Obesity
32, 495–501.
Lifestyle, overweight and gestational diabetes 11
© 2016 John Wiley & Sons Ltd Maternal & Child Nutrition (2016), ••, pp. ••–••
